Delivery Order SPE2DB22D2006-SPE2DB24FV9LC
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $1,556.64 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical division. The award is for the supply of Micardis HCT 80-25 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Micardis HCT 40-12.5 mg tablets. The contract has a ceiling value of $1,641.20 and is a firm-fixed price delivery order with an ultimate completion date of August 12, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
- This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Micardis HCT 40-12.5 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,398.33 and a completion date of December 10, 2024. The contract is not designated with a set-aside. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Micardis HCT 40-12.5 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,765.24, has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order, is for the provision of Micardis HCT 80-25 mg tablet units. The contract has a ceiling value of $3,524.48 and a performance period through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order with a ceiling value of $2,098.93. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and is for the supply of the pharmaceutical product Micardis HCT 80-12.5 mg tablet. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The contract has a ceiling value of $1,920.22 and a period of performance through June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,734.08, is for the delivery of Micardis HCT 40-12.5 mg tablet medications. The contract has an ultimate completion date of February 7, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,503.30 and is for the delivery of Micardis HCT 40-12.5 mg tablets. The contract is a Firm Fixed Price type with an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,512.01 firm fixed-price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets, a medication used to treat hypertension. The contract has an ultimate completion date of October 28, 2022 and was awarded on October 27, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV9LCDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,564,235,096 Micardis HCT 40-12.5 mg tablets. The contract has a ceiling value of $1,195.96 and a performance period through April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This latest delivery order was issued under that IDC. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/10/24 |